EANM/ESC guidelines for radionuclide imaging of cardiac function.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 18224320.
- Also identified by DOI 10.1007/s00259-007-0694-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radionuclide imaging of cardiac function represents a number of well-validated techniques for accurate determination of right (RV) and left ventricular (LV) ejection fraction (EF) and LV volumes. These first European guidelines give recommendations for how and when to use first-pass and equilibrium radionuclide ventriculography, gated myocardial perfusion scintigraphy, gated PET, and studies with non-imaging devices for the evaluation of cardiac function. The items covered are presented in 11 sections: clinical indications, radiopharmaceuticals and dosimetry, study acquisition, RV EF, LV EF, LV volumes, LV regional function, LV diastolic function, reports and image display and reference values from the literature of RVEF, LVEF and LV volumes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "prevailing or general consensus". The guidelines are designed to assist in the practice of referral to, performance, interpretation and reporting of nuclear cardiology studies for the evaluation of cardiac performance.
Medical subject headings
- Europe
- Heart
- Heart/diagnostic imaging
- Heart/physiology
- Heart Function Tests
- Humans
- Myocardial Infarction
- Myocardial Infarction/diagnostic imaging
- Nuclear Medicine
- Nuclear Medicine/standards
- Radioisotopes
- Radionuclide Imaging
- Ventricular Function, Left